A carregar...
Pharmacogenomic potential in advanced cancer patients
PURPOSE: The prevalence of pharmacogenetically actionable medications in advanced cancer patients whose therapy may be optimized with genotype data was determined. METHODS: Patients enrolled in our institutional molecular tumor board observational cohort were included in this study. Collected data i...
Na minha lista:
| Publicado no: | Am J Health Syst Pharm |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7936720/ https://ncbi.nlm.nih.gov/pubmed/31361818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajhp/zxy079 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|